Skip to main content
    N

    Nutex Health Inc (NUTX)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $180.56
    -13.08 (-6.75%)

    Market Cap: $1.41B

    Last updated: Nov 06, 2026 at 4:36 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    67%(10/15)
    Avg Surprise
    -9368.08%
    Streak
    3 Q

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$11.31
    Range$9.17 - $13.33
    6 analysts
    Revenue Consensus
    $213M
    Range$205M - $225M
    6 analysts
    Last 12 of 38 reported quarters and 1 upcoming estimate
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$11.31$9.17 - $13.33--6--
    Sep 26
    Reported Nov 5
    		$5.71$5.53$4.71 - $6.56+3.25%Beat6
    5
    0
    30d
    		-26.4%
    Jun 26
    Reported Aug 6
    		$9.58$5.26$2.87 - $5.58+82.13%Beat5
    2
    0
    30d
    		+83.3%
    Mar 26
    Reported Apr 30
    		$5.74$5.56$5.56 - $5.56+3.24%Beat1
    No revisions (30d)
    		+222.5%
    Dec 25
    Reported Mar 5
    		$1.62N/A--70.85%Miss3
    1
    1
    30d
    		-85.4%
    Sep 25
    Reported Oct 22
    		$7.76$1.95$1.95 - $1.95+297.95%Beat1
    1
    0
    30d
    		+2525.0%
    Jun 25
    Reported Jun 30
    		$5.23$-5.43$-5.43 - $-5.43+196.25%Beat1
    0
    1
    30d
    		+3584.1%
    Mar 25
    Reported May 13
    		$1.78N/A--54.48%Miss2
    1
    0
    30d
    		+3066.7%
    Dec 24
    Reported Mar 31
    		$11.12$-0.12$-0.12 - $-0.12+9118.65%Beat0
    No revisions (30d)
    		+248.3%
    Sep 24
    Reported Nov 8
    		$-0.32$0.28$-0.76 - $0.28-214.29%Miss2
    No revisions (30d)
    		+74.4%
    Jun 24
    Reported Aug 8
    		$-0.15$-0.29$-0.29 - $-0.29+48.28%Beat1
    No revisions (30d)
    		+90.0%
    Mar 24
    Reported May 8
    		$-0.06$0.00$0.00 - $0.00N/ABeat1
    No revisions (30d)
    		+95.8%
    Dec 23
    Reported Mar 28
    		$-7.50$-0.01$-0.01 - $-0.01-149900.00%Miss1
    No revisions (30d)
    		-37400.0%

    Key Metrics

    Valuation
    P/E Ratio7.97EV/EBITDA3.96x
    Price/FCF4.99xFCF Yield20.03%
    Profitability
    Profit Margin21.20%Operating Margin57.80%
    ROE64.60%ROIC32.44%
    Financial Health
    Debt/Equity0.76xInterest Coverage16.22x
    Current Ratio4.76xQuick Ratio4.72x
    Trading Statistics
    Beta2.01Avg Volume139.92K
    52-Week High$226.1652-Week Low$83.99

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$198.47
    SMA 20$199.13
    SMA 50$203.11
    SMA 200$151.28
    EMA 10$194.97
    EMA 20$198.75
    EMA 50$197.33
    EMA 200$165.88

    MACD

    Line: -3.53Signal: -1.42Hist: -2.12

    ADX

    ADX: 18.7+DI: 17.7-DI: 27.9

    Aroon & PSAR

    Aroon Up8.0
    Aroon Down100.0
    PSAR$221.43

    Bollinger Bands

    Upper Band$219.33
    Lower Band$178.93
    %B Position2029%(Upper)
    Band Width0.04

    RSI (14-Day)

    Neutral
    40.6

    Momentum Oscillators

    Stoch %K36.0
    Stoch %D30.1
    Williams %R-80.8
    ROC (10d)-13.9%
    Momentum-29.03
    CCI (20d)-170.4
    MFI (14d)47.4

    Volatility Measures

    ATR (14d)$14.23(7.9%)
    StdDev (20d)10.10
    Hist Vol80.2%(High)

    Volume Flow

    VWAP$180.19
    OBV408.0K
    AD Line-717.1K
    CMF (20d)-0.130

    Volume Metrics

    Avg Vol (20d)136.5K
    Vol Ratio1.2x
    VWMA (20d)$198.14

    Pivot Points

    R3$221.26
    R2$213.88
    R1$203.76
    Pivot Point$196.38
    S1$186.26
    S2$178.88
    S3$168.76

    Advanced Oscillators

    TSI-8.12
    Ultimate Osc43.1
    KST-40.28

    Financial Data

    QuarterSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$217.61M$210.75M$216.49M$151.68M$267.80M$243.99M$211.79M$257.62M$78.80M$76.08M$67.45M$69.67M
    Cost of Revenue$52.55M$48.09M$45.45M$53.44M$42.12M$41.10M$38.66M$34.67M$33.83M$31.99M$32.33M$32.21M
    Gross Profit$101.53M$141.28M$91.73M$46.14M$154.88M$124.92M$118.34M$141.63M$21.92M$22.56M$10.16M$13.21M
    Operating Expenses$87.97M$40.94M$89.77M$67.32M$95.31M$169.21M$92.47M$108.66M$35.30M$38.80M$33.68M$63.60M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$74.96M$32.74M$88.19M$64.74M$77.09M$85.22M$59.73M$88.79M$27.94M$27.65M$29.44M$28.06M
    Operating Income$77.10M$121.72M$81.27M$30.92M$130.37M$33.68M$80.66M$114.29M$9.66M$5.30M$1.45M$-26,145,149
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$4.86M$4.67M$4.68M$4.98M$5.45M$5.68M$6.12M$5.05M$5.38M$5.05M$4.44M$4.24M
    Income Before Tax$72.54M$117.08M$76.56M$25.89M$123.94M$23.73M$71.22M$108.65M$-2,580,000$3.90M$-152,000$-30,710,112
    Income Tax Expense$15.20M$20.77M$13.80M$9.29M$27.14M$7.59M$20.41M$9.15M$4.58M$894,000$390,000$-2,998,470
    Net Income$57.34M$96.32M$62.76M$16.61M$96.80M$16.14M$50.81M$99.50M$-7,165,000$3.01M$-542,000$-27,711,642
    EBITDA$83.02M$127.07M$86.73M$36.06M$134.39M$34.66M$82.43M$118.99M$7.77M$13.49M$8.48M$-21,790,276
    EBIT$77.40M$121.76M$81.24M$30.87M$129.39M$29.41M$77.34M$113.71M$2.80M$8.96M$4.29M$-26,473,428
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about NUTX

    News

    Nine-month operating cash flow hits $188M as quarterly revenue falls at Nutex Health (NUTX).

    Nutex Health reported a decrease in third-quarter 2026 revenue to $217.6 million from $267.8 million a year earlier, with hospital division revenue primarily responsible for the decline. Despite this...

    Stock Titan•11/5/26•Neutral

    Nutex Health Q3 Earnings: Can Cost Savings Offset Revenue Risks?

    Nutex Health (NUTX) is scheduled to report its third-quarter 2026 results, with expectations of subdued revenues despite strong patient volume growth and improved arbitration-related expenses. While cost savings from...

    TradingView•11/4/26•Neutral

    Nutex Health Inc. (NUTX) Seasonal returns chart

    This article provides a seasonal returns chart for Nutex Health Inc. (NUTX), displaying the average monthly price return from 2022 to 2026. The stock's current real-time price on NasdaqCM is also listed. The content is...

    Yahoo Finance UK•11/2/26•Neutral

    Earnings Preview: Nutex Health to Report Financial Results Post-market on November 05

    Nutex Health (NUTX.US) is slated to release its Q3 2026 financial results post-market on November 05 ET. Analysts project a revenue of USD214.82M, a 19.79% year-over-year decrease, and an EPS of USD5.542...

    Moomoo•10/31/26•Somewhat-Bearish

    Nutex Health Inc. (NUTX) Seasonal returns chart

    This article from Yahoo Finance provides a seasonal returns chart for Nutex Health Inc. (NUTX), displaying the average monthly price return from 2022 to 2026. It also includes current stock performance...

    Yahoo Finance Australia•10/31/26•Neutral

    NUTX Valuation and Fair Value

    P/E
    8.0x
    EV/EBITDA
    4.0x
    P/FCF
    5.0x
    P/B
    2.8x
    See GNG's fair value

    NUTX Profitability: Margins, ROIC and FCF

    Gross margin
    47.8%
    Operating margin
    57.8%
    Net margin
    21.2%
    ROIC
    32.4%
    ROE
    64.6%
    FCF margin
    31.1%
    FCF yield
    20.0%

    NUTX Competitors

    CompanyTicker
    Rapport Therapeutics, Inc. Common StockRAPP
    Pennant Group IncPNTG
    Enovis CorpENOV
    Innoviva IncINVA
    UroGen Pharma LtdURGN
    Cronos Group IncCRON
    Phibro Animal Health CorporationPAHC
    Kalvista Pharmaceuticals IncKALV

    Sector: Healthcare

    NUTX Analyst Ratings

    Consensus
    Buy
    Analysts
    5
    Strong Buy
    1
    Buy
    4
    Hold
    0
    Sell
    0
    Strong Sell
    0

    NUTX Bull Case vs Bear Case

    Bull case

    • NUTX earns a 32.4% return on invested capital.
    • NUTX converts 31.1% of revenue into free cash flow.
    • NUTX has a 21.2% net profit margin.

    Bear case

    • NUTX's quarterly revenue changed -13.6% year over year.

    NUTX Earnings: Beat Rate and Next Report

    Beat rate
    6 of 8 quarters (75.0%)
    Average surprise
    1197.0%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $11.31

    NUTX Earnings Date

    NUTX reports Mar 3, 2027. The date is estimated.

    NUTX Earnings Call

    The latest NUTX earnings call transcript on file is labeled 2026Q2.

    Read the 2026Q2 transcript

    NUTX ETF Holders

    GNG tracks 9 ETFs that hold NUTX. The largest weights:

    1. VictoryShares Small Cap Free Cash Flow ETF (SFLO), 0.81% of the fund
    2. First Trust Small Cap Growth AlphaDEX Fund (FYC), 0.60% of the fund
    3. Avantis U.S. Small Cap Value ETF (AVUV), 0.19% of the fund
    4. iShares Russell 2000 ETF (IWM), 0.02% of the fund
    5. Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.01% of the fund
    Open the ETF Stock Exposure tool for NUTX

    See insider activity

    Frequently Asked Questions About NUTX

    When does NUTX report earnings?

    Nutex Health Inc (NUTX) is expected to report earnings on Mar 3, 2027.

    Does NUTX pay dividends?

    Nutex Health Inc (NUTX) does not currently pay a regular dividend.

    What is NUTX's P/E ratio?

    Nutex Health Inc has a price-to-earnings (P/E) ratio of 7.97.

    What is NUTX's market cap?

    Nutex Health Inc (NUTX) has a market capitalization of $1.41B with a current stock price of $180.56.

    Related stocks

    Sector: Healthcare

    All stocks starting with N

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In